{"id":2364,"date":"2019-10-05T20:19:55","date_gmt":"2019-10-05T18:19:55","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2364"},"modified":"2024-06-06T15:47:51","modified_gmt":"2024-06-06T13:47:51","slug":"transformacio-i-metastasi","status":"publish","type":"page","link":"https:\/\/idibell.cat\/recerca\/area-de-cancer\/programa-de-mecanismes-moleculars-i-terapia-experimental-en-oncologia-oncobell\/transformacio-i-metastasi\/","title":{"rendered":"Transformaci\u00f3 i met\u00e0stasi"},"content":{"rendered":"\n
La recerca del grup t\u00e9 com a objectiu identificar noves dianes terap\u00e8utiques per al c\u00e0ncer que es puguin traduir directament en estrat\u00e8gies efectives de prevenci\u00f3 o tractament. Es volen comprendre les vies de senyalitzaci\u00f3 implicades en la regulaci\u00f3 de c\u00e8l\u00b7lules mare epitelials i el desenvolupament del teixit sa, les seves alteracions durant el c\u00e0ncer i la met\u00e0stasi, i les interaccions entre les c\u00e8l\u00b7lules tumorals i el seu\u00a0microambient.<\/p>\n
L’experi\u00e8ncia dels seus membres inclou el desenvolupament de la gl\u00e0ndula mam\u00e0ria, el c\u00e0ncer de mama i la immunologia.<\/p>\n
El grup t\u00e9 un enfocament multidisciplinari i utilitza models de ratol\u00ed modificats gen\u00e8ticament, mostres cl\u00edniques, xenoempelts derivats del pacient, organoides i cultius 3D, i t\u00e8cniques de biologia molecular i cel\u00b7lular per traduir la investigaci\u00f3 b\u00e0sica en resultats cl\u00ednicament rellevants.<\/p>\n
<\/p>\n
El grup ha rebut un finan\u00e7ament competitiu ininterromput d’organismes p\u00fablics i privats, nacionals i internacionals, amb un total de 17 beques. Entre les ag\u00e8ncies finan\u00e7adores destaquen: MINECO, ISCIII, AECC, Fundaci\u00f3 Mutua Madrile\u00f1a, Marat\u00f3 de TV3, i tamb\u00e9 les ag\u00e8ncies internacionals m\u00e9s prestigioses (Concern Foundation (EUA), Susan G. Komen Foundation (EUA)). Recentment, ha rebut una ERC Consolidator Grant de la Uni\u00f3 Europea adre\u00e7ada a la Dra. Gonz\u00e1lez Su\u00e1rez.<\/p>\n
El grup tamb\u00e9 ha signat contractes amb la ind\u00fastria i coordina assaigs cl\u00ednics de fase inicial.<\/p>\n
<\/p>\nReferencia: 682935
\nT\u00edtulo: PLEIO-RANK: Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity
\nFinanciador: ERC – H2020
\nAgradecimiento: European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program\n
<\/p>\n
<\/p>\nReferencia: SLT006\/17\/00122
\nTipo: “CONTRACTES D’INCORPORACI\u00d3 DE CIENT\u00cdFICS I TECN\u00d2LEGS ALS GRUPS DE RECERCA”
\nFinanciador: DEPARTAMENT DE SALUT
\nAgradecimiento: Departament de Salut de la Generalitat de Catalunya mitjan\u00e7ant l’Acci\u00f3 instrumental d’incorporaci\u00f3 (PERIS).\n
<\/p>\n
<\/p>\nReferencia: BES-2015-071675
\nTipo: “AYUDAS PARA CONTRATOS PREDOCTORALES PARA LA FORMACI\u00d3N DE DOCTORES 2015”
\nFinanciador: Ministerio de Ciencia, Innovaci\u00f3n y Universidades
\nAgradecimiento: Ministerio de Ciencia, Innovaci\u00f3n y Universidades, perteneciente a la Agencia Estatal de Investigaci\u00f3n (AEI). Cofinanciado por el Fondo Social Europeo. FSE invierte en tu futuro\n
<\/p>\n
<\/p>\nReferencia: PRE2018-086522
\nTipo: “AYUDAS PARA CONTRATOS PREDOCTORALES PARA LA FORMACI\u00d3N DE DOCTORES 2018”
\nFinanciador: Ministerio de Ciencia, Innovaci\u00f3n y Universidades
\nAgradecimiento: Ministerio de Ciencia, Innovaci\u00f3n y Universidades, perteneciente a la Agencia Estatal de Investigaci\u00f3n (AEI). Cofinanciado por el Fondo Social Europeo. FSE invierte en tu futuro\n
<\/p>\n
<\/p>\nReferencia: IJCI-2017-31564
\nTipo: “AYUDAS JUAN DE LA CIERVA – INCORPORACION 2017”
\nFinanciador: Ministerio de Ciencia, Innovaci\u00f3n y Universidades
\nAgradecimiento: Ministerio de Ciencia, Innovaci\u00f3n y Universidades, perteneciente a la Agencia Estatal de Investigaci\u00f3n (AEI).\n
<\/p>\nReferencia: FJCI-2017-31565
\nTipo: “AYUDAS JUAN DE LA CIERVA – FORMACION 2017”
\nFinanciador: Ministerio de Ciencia, Innovaci\u00f3n y Universidades
\nAgradecimiento: Ministerio de Ciencia, Innovaci\u00f3n y Universidades, perteneciente a la Agencia Estatal de Investigaci\u00f3n (AEI).\n
<\/p>\n
<\/p>\nReferencia: IDEAS19093GONZ
\nT\u00edtulo: RANK, instead of RANKL, as a new therapeutic target in Triple Negative Breast Cancer
\nFinanciador: Fundaci\u00f3n Cient\u00edfica de la AECC
\nAgradecimiento: Fundaci\u00f3n Cient\u00edfica de la Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer\n
<\/p>\n
<\/p>\nSAF2017-86117-R. New insights in RANK signaling pathway: from biology to treatment
\nPI: Gonz\u00e1lez-Su\u00e1rez, Eva
\nMinisterio de Ciencia, Innovaci\u00f3n y Universidades, perteneciente a la Agencia Estatal de Investigaci\u00f3n (AEI).\nCofinanciado por el Fondo Europeo de Desarrollo Regional. FEDER, una manera de hacer Europa. Promover el desarrollo tecnol\u00f3gico, la innovaci\u00f3n y una investigaci\u00f3n de calidad.
\n\n
<\/p>\n\t\t\t\t\n
Transformaci\u00f3 i met\u00e0stasi Resum La recerca del grup t\u00e9 com a objectiu identificar noves dianes terap\u00e8utiques per al c\u00e0ncer que es puguin traduir directament en estrat\u00e8gies efectives de prevenci\u00f3 o tractament. Es volen comprendre les vies de senyalitzaci\u00f3 implicades en la regulaci\u00f3 de c\u00e8l\u00b7lules mare epitelials i el desenvolupament del teixit sa, les seves alteracions […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":448,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-2364","page","type-page","status-publish","hentry"],"publishpress_future_action":{"enabled":false,"date":"2024-12-29 10:08:07","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=2364"}],"version-history":[{"count":7,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2364\/revisions"}],"predecessor-version":[{"id":25895,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2364\/revisions\/25895"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/448"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=2364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}